Anthony Richards, PharmD

Director
Cytokinetics, Inc

Poster(s):

• (31) Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
  Wednesday, October 29, 2025